Ruti Aga: A Forged Prescription Turned a Two-Year Sanction Into Six

The prescription had a name on it, an address for a clinic, and a drug: methylprednisolone, for a knee injury. The prescription was not real. The address was not real; no clinic existed at it. And the person who wrote it was a member of Ruti Aga's own family, a man with no medical registration, who explained, when asked, that he had used “an old prescription pad from a former workplace.” The Athletics Integrity Unit contacted the clinic. The clinic disowned the pad outright.

Three checks, three disavowals. The paper did not hold anywhere.

That paper is now the most expensive document of Aga's career. The 32-year-old Ethiopian marathoner has been banned for six years, effective from 10 September — the same date her provisional suspension began. The AIU released its statement on a Thursday; the statement does not give the year.

What the file leaves out has to be counted too. Patiala taught me that. In 2026, when I was stitching together the paper trail of six women's bans by phone from Miami, the important question was not the one in the federation's note. The important question was what the note had left out. It is the same here: no test date, no year for the sample, no mark from the Chinese race, no scope of disqualification.

And one thing the file does contain, it contains wrongly. Most reports called methylprednisolone a “prohibited steroid,” “classed as performance enhancing by WADA.” That is technically imprecise. Methylprednisolone is a glucocorticoid — class S9 on the WADA Prohibited List — not an anabolic steroid (S1). The S9 condition is the decisive one: prohibited in-competition only, and only by injection, oral or rectal route. A therapeutic knee injection, given out of competition, is entirely legal. It becomes a violation only if residues are present in a sample collected in-competition.

The case was never a steroid case. It was a route-and-timing case. Which is why everything comes to rest on that prescription — because the road she could have walked required real paper.

Context

Aga is not a marginal name. She won the 2026 Tokyo Marathon — my register has 2:20:40 that day, though the AIU statement gives no mark. She was second at Berlin in 2026 — 2:18:34 in my notes. She has three second-place finishes at World Marathon Majors. A 2:18–2:20 performer does not select herself onto an Ethiopian women's marathon team; the depth is such that one athlete's removal does not register in the national arithmetic. The Ethiopian system runs on altitude clubs, agent-driven training groups and races that pay appearance fees. There are no franchise contracts and no salary cap, which is why form is an economic asset.

In March, Aga won a half marathon in China. The source gives no mark, no splits, no field quality. There is one solid fact: she won it, and the sample from that race produced the violation. “Won” implies a Label-tier elite field with in-competition testing. Everything else is inference, and should be labelled as such.

That circuit needs explaining. Chinese label races are the income tier between Majors for East African marathoners — decent appearance fees, low race count, low risk. A pipeline is just a visa stamp with a story; here the stamp is a receipt for an appearance fee. That same tier is now the AIU's highest-yield testing ground. The fee economy and the testing economy are colliding in the same races.

The institutional frame is small, so take it one clause at a time. The AIU enforces World Athletics' anti-doping rules under the WADA Code (2026) and the WADA Prohibited List. A TUE is a therapeutic use exemption — a permit that makes a prohibited drug legal for treatment in advance. And “Specified Substance” is the category of drugs that also have legitimate medical use, which is why the base sanction is lighter and intent has room to be argued. Methylprednisolone sits on that side of the line.

The timing arithmetic sits here too. In road racing the in-competition testing window opens at 23:59 the day before the race. An injection given days earlier can be caught if the washout period does not fit. This case fell inside that window.

Core

Start with the sanction arithmetic, because it speaks most clearly. Two years plus four years equals six. Two years for the presence violation — the base sanction for a substance in this category where intent was not proven. Four years for tampering — the Code's standard sanction for fabricating documents and giving misleading statements during an investigation.

The six years are not one sanction; they are two, stacked — and that is the actual news of the case.

The arithmetic yields something else: the panel rejected the no-significant-fault mitigation. Had it been granted, the presence sanction could have dropped below two years. It did not. The prescription is why.

Understand the point that reporting has lost. An S9 substance is prohibited in-competition only. That means Aga had a legitimate defence available: route, timing and medical necessity. Real medical records, the date of the injection, the treating physician's registration, the clinic's file — these could have built the argument that the drug was therapeutic and should have washed out before the race; and that if residue remained, it was negligence, not deception. On that road the sanction could have been far shorter — possibly with no tampering charge at all.

The prescription destroyed that defence. The paper that was meant to save her is the paper that buried her.

Look at the three verification failures separately, because they are different in kind. One: no clinic existed at the address — the place was invented. Two: the author had no medical registration — the authority was invented. Three: the clinic disowned the “old pad” — the source was invented. Had the paper held at any one point, the shape of the case would have changed. It failed at all three.

Add a subtlety that reads as a paradox at first glance. A forged document is itself circumstantial evidence of intent to conceal — yet it did not escalate the presence sanction. What that means is the panel weighed the two charges on separate scales: intent was not proven on the substance, hence the base sanction; culpability was fully proven on the paper, hence the standard sanction. This is not exculpation. It is two files added together.

Now the root cause, which is one line in the statement and everything in the story: the knee injury. Chronic knee synovitis is common in high-volume marathon training — a load-bearing failure more than an accident. Intra-articular or peri-articular methylprednisolone is standard sports-medicine practice for it. Masking pain is also an economic necessity for a marathoner: appearance fees are paid for showing up, not for form. The cheapest, most available tool is a glucocorticoid. And when the medical network around an athlete is informal, the paperwork goes informal too.

This is not one runner's lapse; it is a case about an empty chair — the chair in the team where a credentialed physician should have been sitting.

Had the chair been filled, two routes were open: obtain a TUE, or observe WADA's route-specific washout period. Neither happened. A prescription was produced instead. In thirty-seven years of notebooks this pattern is not new — in 2026 I reached a chemist's receipts near NIS Patiala the same way, because the question was never who took what; it was who bought what and who failed to log it. I have kept a standing crisis file ever since, with one rigid rule: a ban is reported with the test date, the substance and the appeal window, never as a single verdict. In this case two of those three are simply absent from the source.

One more thing emerges from the shape of the tampering charge: the four years did not come from the document alone, but from statements made under questioning. Language and translation in AIU interviews with Ethiopian athletes has been a recurring point of contention — that is my read, not a documented finding, and I am filing it as such. Had the language of the interview been contested, half the weight of the tampering charge could have shifted. The file is silent on it.

Backdating the ban to 10 September is no relief. Provisional suspension time counts against the sanction; it is a procedural benefit, not a reduction. That date is simply when she was already out.

The career math is direct. Six years at 32 means a return at roughly 38. In the depth of Ethiopian women's marathoning, a 38-year-old with a doping record on her name is not selectable. Six years on paper; the end of a career in practice.

What survives? The 2026 Tokyo title and three Major second places — results that predate the violation and are not automatically annulled absent a finding of earlier use. The source does not state the scope of disqualification, and that is the largest hole in the file. Standard AIU practice voids the result and prize money of the competition where the sample was collected, along with ranking points accrued after that date. So the March win, its purse and its points are all in jeopardy. The statement does not say so; the arithmetic does.

For road racing I keep the same five-column ledger I keep for the javelin — entry list, purse, test window, agent, medical staff. The fifth column is the one nobody fills. Had it been filled here, this story would not exist.

Contrarian

From outside, the case looks simple: another doper caught, the AIU is tough. That reading is convenient and mostly wrong.

This is not a doping verdict; it is a document-verification verdict. The bulk of the six years attaches not to the substance but to the paper manufactured to legitimise it. A glucocorticoid has no proven endurance benefit; it reduces swelling, it reduces pain. Six years for something that does not make you faster and six years for something that does are different species of case, and putting them in one bucket is a reporting error. Outlets that called this a “steroid” placed it, without meaning to, alongside S1 cases it should never be compared with.

The second inverted angle: the enforcement frontier has moved. The fight used to be about detection — sample, lab, result. It is now about paper — prescription, receipt, clinic registration, statements given in interview. In East African road-running cases, tampering is the AIU's most frequently used second charge. The implication is that athletes caught on a first violation often end up in a heavier second one because they have no legitimate defence infrastructure around them. Paper gets replaced by paper. That is pattern recognition, not a documented finding in any single case.

Third: the proportionality argument. A six-year ban will be cited as evidence of inconsistent enforcement against African road runners. There is force in that argument — and in this case it is only half the argument. The aggravating fact was supplied by the athlete herself. The moment a competitor fabricates a document, she becomes the weakest possible example for the case that could have been made on her behalf.

And look at who was not charged. The statement names the family member. The agent, the management, the medical adviser to the training group — none is named. Someone suggested or accepted that paper; whether that was part of the investigation is unknown. Document forgery sits outside the AIU's jurisdiction — it may be a matter for national law — and the statement gestures nowhere near it. No statement from the Ethiopian federation is quoted either. I followed the kit bag, not the press release; here the pad was inside the kit bag, and the press release contains only the athlete's name.

Takeaway

Three things to watch.

First, the appeal window. A reasoned decision normally opens roughly 21 days to go to CAS. A document-based finding is hard to overturn, which makes an appeal unlikely and expensive.

Second, whether anything happens nationally on the forgery. If nothing does, the message is clear: the price of a fake document is a sporting ban, and only if you are caught.

Third, and most important — whether the AIU next charges the people who commission these documents. As long as the sanction reaches only the runner, that chair stays empty and that pad comes out of another drawer. A six-year ban casts a longer shadow than six races — but the shadow falls on the one who was caught, not the one who handed over the paper.

The question is not who gets caught next. It is who signs the next prescription — and whether anyone checks the signature.